Abstract
Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory condition with increasing incidence and prevalence around the world. Although B cells had generally been believed to play a pathogenic role in IBD due to the production of autoantibodies, a growing body of evidence from mouse models suggests the coexistence of pathogenic B cells and regulatory B cells, termed Breg, in this disorder. Since some unique techniques are required to closely study the Breg in gut-associated lymphoid tissues (GALT), we herein describe how to induce colitis in mice and how to analyze the phenotype and function of GALT-specific Breg.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427–434
Kaser A, Zeissig S, Blumberg RS (2010) Inflammatory bowel disease. Annu Rev Immunol 28:573–621
Talley NJ, Abreu MT, Achkar JP et al (2011) American College of Gastroenterology IBD Task Force. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 106:S2–S25
Molodecky NA, Soon IS, Rabi DM et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54
Targan SR, Karp LC (2005) Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev 206:296–305
Mombaerts P, Mizoguchi E, Grusby MJ et al (1993) Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:274–282
Ma A, Datta M, Margosian E et al (1995) T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J Exp Med 182:1567–1572
Mizoguchi A, Mizoguchi E, Smith RN et al (1997) Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med 186:1749–1756
Wei B, Velazquez P, Turovskaya O et al (2005) Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A 102:2010–2015
Ray A, Basu S, Williams CB et al (2012) A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J Immunol 188:3188–3198
Moritoki Y, Lian ZX, Lindor K et al (2009) B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice. Hepatology 50:1893–1903
Gerth AJ, Lin L, Neurath MF et al (2004) An innate cell-mediated, murine ulcerative colitis-like syndrome in the absence of nuclear factor of activated T cells. Gastroenterology 126:1115–1121
Shinzaki S, Iijima H, Fujii H et al (2012) Altered oligosaccharide structures reduce colitis induction in mice defective in β-1, 4-galactosyltransferase. Gastroenterology 142:1172–1182
Kirkland D, Benson A, Mirpuri J et al (2012) B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity 36:228–238
Mizoguchi A, Mizoguchi E, Takedatsu H et al (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16:219–230
Sugimoto K, Ogawa A, Shimomura Y et al (2007) Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation. Gastroenterology 133:124–136
Mizoguchi E, Mizoguchi A, Preffer FI et al (2000) Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol 12:597–605
Mizoguchi A, Bhan AK (2006) A case for regulatory B cells. J Immunol 176:705–710
Schmidt EG, Larsen HL, Kristensen NN et al (2012) B cells exposed to enterobacterial components suppress development of experimental colitis. Inflamm Bowel Dis 18:284–293
Yanaba K, Yoshizaki A, Asano Y et al (2011) IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol 178:735–743
Dass S, Vital EM, Emery P (2007) Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum 56:2715–2718
Tayal V, Chiu YH, George E et al (2011) Colitis associated with active systemic lupus erythematosus successfully treated with rituximab. J Clin Rheumatol 17:79–82
Leiper K, Martin K, Ellis A et al (2011) Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis. Gut 60:1520–1526
Goetz M, Atreya R, Ghalibafian M et al (2007) Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 13:1365–1368
El Fassi D, Nielsen CH, Junker P et al (2011) Systemic adverse events following rituximab therapy in patients with Graves’ disease. J Endocrinol Invest 34:e163–e167
Ardelean DS, Gonska T, Wires S et al (2010) Severe ulcerative colitis after rituximab therapy. Pediatrics 126:e243–e246
Bhalme M, Hayes S, Norton A et al (2013) Rituximab-associated colitis. Inflamm Bowel Dis 19:E41–E43
Sekkach Y, Hammi S, Elqatni M et al (2011) Ulcerative colitis: exceptional consequence after rituximab therapy. Ann Pharm Fr 69:265–269
Nishida A, Nagahama K, Imaeda H et al (2012) Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cells. J Exp Med 209:2383–2394
Bouabe H (2012) Cytokine reporter mice: the special case of IL-10. Scand J Immunol 75:553–567
Madan R, Demircik F, Surianarayanan S et al (2009) Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol 183:2312–2320
Mizoguchi A (2012) Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci 105:263–320
Mishima Y, Ishihara S, Aziz MM et al (2010) Decreased production of interleukin-10 and transforming growth factor-beta in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice. Immunology 131:473–487
Shimomura Y, Mizoguchi E, Sugimoto K et al (2008) Regulatory role of B-1 B cells in chronic colitis. Int Immunol 20:729–737
Shimomura Y, Ogawa A, Kawada M et al (2008) A unique B2 B cell subset in the intestine. J Exp Med 205:1343–1355
Mauri C, Bosma A (2012) Immune regulatory function of B cells. Annu Rev Immunol 30:221–241
Mackay F, Figgett WA, Saulep D et al (2010) B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor. Immunol Rev 237:205–225
Acknowledgments
The study has been supported primarily by NIH RO1AI081807 and partially by RO1DK091247.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Nishida, A., Lau, C.W., Mizoguchi, E., Mizoguchi, A. (2014). Regulatory B Cells in Mouse Models of Intestinal Inflammation. In: Vitale, G., Mion, F. (eds) Regulatory B Cells. Methods in Molecular Biology, vol 1190. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1161-5_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1161-5_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1160-8
Online ISBN: 978-1-4939-1161-5
eBook Packages: Springer Protocols